Shizuoka, Japan

Akemi Mizutani

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2011-2016.

USPTO Granted Patents = 4 

% Patents Active = 50.0

 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Akemi Mizutani: Innovator in Pharmaceutical Chemistry

Introduction

Akemi Mizutani is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on spiroimidazolone derivatives. With a total of four patents to her name, Mizutani continues to push the boundaries of scientific research and development.

Latest Patents

Mizutani's latest patents focus on spiroimidazolone derivatives. The first patent describes a compound represented by a specific formula, wherein various components are defined in the claims. This compound is noted for its potential pharmacological applications. The second patent also pertains to a spiroimidazolone derivative, reiterating the importance of this compound in her research.

Career Highlights

Mizutani is currently employed at Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her work at Chugai has allowed her to collaborate with other talented scientists and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Some of her notable coworkers include Toru Esaki and Yoshikazu Nishimura. Their collaborative efforts have further enhanced the innovative environment at Chugai Seiyaku Kabushiki Kaisha.

Conclusion

Akemi Mizutani is a remarkable inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. Her contributions, particularly in the area of spiroimidazolone derivatives, highlight her dedication to innovation and research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…